Chevy Chase Trust Holdings LLC increased its holdings in Welltower Inc. (NYSE:WELL – Get Rating) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 285,391 shares of the real estate investment trust’s stock after buying an additional 8,787 shares during the period. Chevy Chase Trust Holdings LLC owned about 0.06% of Welltower worth $18,357,000 as of its most recent filing with the SEC.
→ Is This The End of Capitalism? (From Porter & Company)
Other hedge funds and other institutional investors have also modified their holdings of the company. Alta Advisers Ltd acquired a new position in shares of Welltower in the 3rd quarter valued at about $84,000. Los Angeles Capital Management LLC boosted its holdings in shares of Welltower by 50.4% in the 2nd quarter. Los Angeles Capital Management LLC now owns 13,707 shares of the real estate investment trust’s stock valued at $1,129,000 after buying an additional 4,596 shares during the period. Oppenheimer & Co. Inc. boosted its stake in Welltower by 7.7% during the 2nd quarter. Oppenheimer & Co. Inc. now owns 30,054 shares of the real estate investment trust’s stock valued at $2,475,000 after purchasing an additional 2,145 shares during the period. Swiss National Bank boosted its stake in Welltower by 2.9% during the 2nd quarter. Swiss National Bank now owns 1,940,280 shares of the real estate investment trust’s stock valued at $159,782,000 after purchasing an additional 55,000 shares during the period. Finally, Benson Investment Management Company Inc. acquired a new position in Welltower during the 3rd quarter valued at about $2,809,000. 95.78% of the stock is owned by institutional investors and hedge funds.
Welltower Stock Up 0.4 %
NYSE WELL opened at $74.18 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.11 and a quick ratio of 2.11. The company’s 50 day simple moving average is $68.49 and its 200 day simple moving average is $70.83. Welltower Inc. has a 12 month low of $56.50 and a 12 month high of $99.43. The company has a market capitalization of $35.05 billion, a P/E ratio of 161.26, a PEG ratio of 4.28 and a beta of 1.02.
Welltower Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, November 30th. Investors of record on Friday, November 18th were issued a $0.61 dividend. The ex-dividend date was Thursday, November 17th. This represents a $2.44 dividend on an annualized basis and a dividend yield of 3.29%. Welltower’s payout ratio is currently 530.45%.
Analyst Ratings Changes
A number of research firms have issued reports on WELL. Evercore ISI lowered shares of Welltower from an “outperform” rating to an “in-line” rating and set a $72.00 target price for the company. in a research note on Monday, November 21st. Barclays boosted their target price on shares of Welltower from $78.00 to $82.00 and gave the company an “overweight” rating in a research note on Tuesday, January 17th. Mizuho reduced their target price on shares of Welltower from $93.00 to $91.00 in a research note on Friday, December 2nd. StockNews.com began coverage on shares of Welltower in a research note on Wednesday, October 12th. They set a “sell” rating for the company. Finally, Raymond James raised shares of Welltower from an “outperform” rating to a “strong-buy” rating and boosted their target price for the company from $72.00 to $82.00 in a research note on Monday, January 9th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Welltower has an average rating of “Moderate Buy” and an average target price of $82.56.
Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to email@example.com.
Before you consider Welltower, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Welltower wasn’t on the list.
While Welltower currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.